Deciphera Pharmaceuticals, Inc. Current Foreign Tax Expense (Benefit)
Deciphera Pharmaceuticals, Inc. reported Current Foreign Tax Expense (Benefit) of $431.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. current foreign tax expense (benefit) for fiscal 2023 was $431.00K, a 22.48% decline from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. current foreign tax expense (benefit) for fiscal 2022 was $556.00K.
- Deciphera Pharmaceuticals, Inc. current foreign tax expense (benefit) for fiscal 2021 was $0.00.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2023-12-31 | $431.00K 10-K · filed 2024-02-07 |
| 2022-12-31 | $556.00K 10-K · filed 2024-02-07 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-07 |